ValUe of Screening MRI Brain in Patients With Newly Diagnosed Stage IV Non-oncogene Addicted Non-small Cell Lung CANcer - The VULCAN Trial
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Patients with newly diagnosed stage IV non-oncogene addicted NSCLC, who are fit for systemic treatment and don't have any symptoms of brain disease will undergo an MRI of the brain to screen for brain disease.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Histologically or cytologically confirmed stage IV metastatic NSCLC, not amenable to curative treatment.
• Fit for systemic treatment (PS 0-2) according to standard of care.
• No symptoms of brain disease disease assessed according to standard clinical care by the thoracic oncologist.
Locations
Other Locations
Netherlands
University Medical Center Groningen
RECRUITING
Groningen
Contact Information
Primary
F. Bensch, MD, PhD
f.bensch@umcg.nl
0031503616161
Backup
L.B.M. Hijmering, MD
l.b.m.hijmering-kappelle@umcg.nl
0031503616161
Time Frame
Start Date: 2024-05-13
Estimated Completion Date: 2026-07-01
Participants
Target number of participants: 100
Treatments
Experimental: Screening population
Patients with newly diagnosed stage IV non-oncogene addicted NSCLC, who are fit for systemic treatment and don't have any symptoms of brain disease.
Related Therapeutic Areas
Sponsors
Leads: University Medical Center Groningen